For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Impact BioMedical Inc’s stock clocked out at $0.96, up 14.50% from its previous closing price of $0.84. In other words, the price has increased by $14.50 from its previous closing price. On the day, 16.38 million shares were traded.
Ratios:
To gain a deeper understanding of IBO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.17 and its Current Ratio is at 0.22. In the meantime, Its Debt-to-Equity ratio is 2.38 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 22 ’25 when DSS, INC. sold 115,600 shares for $0.55 per share. The transaction valued at 63,476 led to the insider holds 45,400 shares of the business.
DSS, INC. sold 45,400 shares of IBO for $24,530 on May 27 ’25. The 10% Owner now owns 0 shares after completing the transaction at $0.54 per share. On Apr 04 ’25, another insider, DSS, INC., who serves as the 10% Owner of the company, sold 890,800 shares for $0.95 each. As a result, the insider received 845,013 and left with 161,100 shares of the company.
Stock Price History:
Over the past 52 weeks, IBO has reached a high of $6.17, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is 79.98%, while the 200-Day Moving Average is calculated to be -37.21%.
Shares Statistics:
A total of 12.09M shares are outstanding, with a floating share count of 11.98M. Insiders hold about 0.85% of the company’s shares, while institutions hold 3.19% stake in the company.
